Altered long noncoding RNA profile after intracerebral hemorrhage

Area of Science:

• Neuroscience
• Molecular Biology
• Genomics

Background:

• Intracerebral hemorrhage (ICH) is a severe neurological condition with limited treatment options.
• Understanding the molecular mechanisms underlying ICH is crucial for developing effective therapies.
• Long noncoding RNAs (lncRNAs) are emerging as key regulators of cellular processes, but their role in ICH is not fully understood.

Purpose of the Study:

• To investigate the expression patterns of lncRNAs and messenger RNAs (mRNAs) in rat models of ICH.
• To identify specific lncRNAs and their potential roles in the pathophysiology of ICH.
• To analyze gene ontology and gene/protein interactions related to altered RNA expression post-ICH.

Main Methods:

• Two distinct rat models of ICH were established: collagenase injection and autologous blood injection.
• Microarray analysis was employed to compare lncRNA and mRNA expression in hemorrhagic versus normal brain tissue at various time points (1, 3, and 7 days post-ICH).
• Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was used for validation, alongside gene ontology and pathway analyses for differentially expressed genes and protein-protein interactions.

Main Results:

• A significant number of lncRNAs (83, 289, and 401) were found to be upregulated at 1, 3, and 7 days, respectively, after collagenase-induced ICH.
• The lncRNA NR_027324, also known as H19, was the most consistently upregulated transcript in both ICH models, with elevated levels persisting up to 7 days.
• Gene ontology analysis indicated an upregulation of immune-related biological processes, and protein interaction studies linked NR_027324 to the type I interferon signaling pathway.

Conclusions:

• The study demonstrates a dynamic and significant alteration in the lncRNA expression profile following ICH.
• H19 (NR_027324) emerges as a key, consistently upregulated lncRNA in the context of ICH.
• These findings provide insights into the molecular landscape of ICH and highlight H19 as a potential therapeutic target or biomarker.